Avalo Therapeutics, Inc.

AVTXNASDAQHealthcare● Active

$12.99

$-0.11(-0.80%)

Market Cap$146764792

P/E Ratio—

52W High$24.27

52W Low$4.06

Avg Volume1.5M

Open$13.25

Beta0.82

Employees Ownership Insider Trades

Avalo Therapeutics, Inc. (AVTX) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · AVTX · as of Mar 23, 2026

Latest filing snapshot

+10+43.48%vs prior year

Avalo Therapeutics, Inc. (AVTX) employee data is sourced from the annual SEC 10-K filing. As of 2025, full-time employees only. Global consolidated headcount. View SEC filing ↗

SEC 10-K·Period end: 2025-12-31·Full-time · Global

Total Employees

Change (1Y)

+10

Growth % (1Y)

+43.48%

Revenue / Employee

$1.8K

Net Income / Employee

$-2.37M

Market Cap

$147M

AVTX Employee Count

2015 – 2025 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing Date	Period End	Employees	Change (1Y)	Growth (1Y)
2026-03-23	2025-12-31	33	+10	+43.48%
2025-03-20	2024-12-31	23	+4	+21.05%
2024-03-29	2023-12-31	19	-1	-5.00%
2023-03-29	2022-12-31	20	-24	-54.55%
2022-03-02	2021-12-31	44	+12	+37.50%
2021-03-08	2020-12-31	32	+14	+77.78%
2020-03-11	2019-12-31	18	-46	-71.88%
2019-03-18	2018-12-31	64	+26	+68.42%
2018-04-02	2017-12-31	38	+23	+153.33%
2017-03-14	2016-12-31	15	+2	+15.38%

▸ Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology

#SymbolCompanyEmployeesMkt Cap

CHRS

Coherus Oncology, Inc.

228$177M #2

CRBU

Caribou Biosciences, Inc.

147$184M #3

ENTA

Enanta Pharmaceuticals, Inc.

131$254M #4

AVTX

Avalo Therapeutics, Inc.YOU

33$147M #5

EPRX

Eupraxia Pharmaceuticals Inc.

33$202M #6

BDTX

Black Diamond Therapeutics, Inc.

24$110M #7

AARD

Aardvark Therapeutics, Inc. Common Stock

22$79M

Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · AVTX peer comparison

About AVTX employees

AVTX Employees · Headcount

Avalo Therapeutics, Inc. (AVTX) employee data is sourced from the annual SEC 10-K filing. As of 2025, Avalo Therapeutics, Inc. had 33 full-time employees globally. Full-time employees only. Global consolidated headcount.

Avalo Therapeutics, Inc. employs 33 full-time employees as of the latest filing within the Biotechnology industry. Revenue per employee stands at $1,788, reflecting the company's operational efficiency.

Avalo Therapeutics, Inc.'s workforce increased by 10 (43.48%) in 2025 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

Avalo Therapeutics, Inc.'s revenue per employee of $1,788 positions it among the notable performers in the Biotechnology sector for operational efficiency.

Revenue Financial statements Net income SEC filings Price history Forecast & ratings Ownership Earnings

Frequently Asked Questions

AVTX Employees · 5 questions

As of the latest SEC 10-K filing (2025), Avalo Therapeutics, Inc. had 33 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

Avalo Therapeutics, Inc. employee counthow many employees does Avalo Therapeutics, Inc. haveAVTX total employees 2025

▸ Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2026-03-23